Estrogens, bone mass, and osteoporotic fracture (Q36822497)

16 August 2017

1 reference

title

Estrogens, bone mass, and osteoporotic fracture (English)

1 reference

16 August 2017

0 references

1 reference

R. Lindsay

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1750409

15 November 2022

language of work or name

English

0 references

publication date

1 November 1991

1 reference

16 August 2017

25 November 1991

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1750409

full work available at URL

15 November 2022

https://api.elsevier.com/content/article/PII:000293439190240X?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90240-X

https://api.elsevier.com/content/article/PII:000293439190240X?httpAccept=text/plain

15 November 2022

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90240-X

American Journal of Medicine

15 November 2022

published in

1 reference

16 August 2017

91

1 reference

16 August 2017

10S-13S

1 reference

16 August 2017

5B

1 reference

Estrogens, bone loss and preservation

16 August 2017

2

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90240-X

Osteoporosis after oophorectomy for non-malignant disease in premenopausal women.

15 November 2022

3

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90240-X

Menopausal changes in bone remodeling

15 November 2022

4

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90240-X

Menopausal changes in calcium balance performance

15 November 2022

5

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90240-X

Early menopausal changes in bone mass and sex steroids.

15 November 2022

7

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90240-X

The effect of endogenous oestrogen on plasma and urinary calcium and phosphate in oophorectomized women.

15 November 2022

8

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90240-X

Endogenous oestrogen and bone loss following oophorectomy

15 November 2022

9

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90240-X

Estrogen treatment of patients with established postmenopausal osteoporosis

15 November 2022

10

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90240-X

Bone mineral content of amenorrheic and eumenorrheic athletes

15 November 2022

11

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90240-X

Decreased bone density in hyperprolactinemic women

15 November 2022

13

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90240-X

Exercise-induced amenorrhea and bone density

15 November 2022

14

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90240-X

A randomized study on the effects of estrogen/gestagen or high dose oral calcium on trabecular bone remodeling in postmenopausal osteoporosis

15 November 2022

15

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90240-X

Quantum concept of bone remodeling and turnover: Implications for the pathogenesis of osteoporosis

15 November 2022

16

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90240-X

A simple method for correlative light and scanning electron microscopy of human iliac crest bone biopsies: qualitative observations in normal and osteoporotic subjects

15 November 2022

17

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90240-X

Long-term prevention of postmenopausal osteoporosis by oestrogen. Evidence for an increased bone mass after delayed onset of oestrogen treatment

15 November 2022

18

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90240-X

Prevention of spinal osteoporosis in oophorectomised women

15 November 2022

19

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90240-X

The minimum effective dose of estrogen for prevention of postmenopausal bone loss

15 November 2022

20

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90240-X

Long term effect of oestrogen replacement therapy on bone mass as measured by dual photon absorptiometry.

15 November 2022

21

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90240-X

Prevention of early postmenopausal bone loss: controlled 2-year study in 315 normal females

15 November 2022

22

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90240-X

Prospective trial of oestrogen and calcium in postmenopausal women.

15 November 2022

23

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90240-X

Effect of Estrogens and Calcium Carbonate on Bone Loss in Postmenopausal Women

15 November 2022

24

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90240-X

Effects of transdermal versus oral hormone replacement therapy on bone density in spine and proximal femur in postmenopausal women

15 November 2022

27

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90240-X

The effect of percutaneous estradiol and natural progesterone on postmenopausal bone loss

15 November 2022

28

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90240-X

17 Beta-estradiol and continuous norethisterone: a unique treatment for established osteoporosis in elderly women

15 November 2022

30

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90240-X

Estrogen therapy arrests bone loss in elderly women

15 November 2022

31

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90240-X

Postmenopausal bone loss is prevented by treatment with low-dosage estrogen with calcium

15 November 2022

32

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90240-X

Decreased risk of fractures of the hip and lower forearm with postmenopausal use of estrogen

15 November 2022

33

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90240-X

Post-menopausal oestrogens protect against fractures of hip and distal radius. A case-control study

15 November 2022

34

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90240-X

An epidemiologic study of hip fracture in postmenopausal women

15 November 2022

35

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90240-X

Long-term estrogen replacement therapy prevents bone loss and fractures

15 November 2022

36

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90240-X

Estrogen binding, receptor mRNA, and biologic response in osteoblast-like osteosarcoma cells

15 November 2022

38

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90240-X

Evidence of estrogen receptors in normal human osteoblast-like cells

15 November 2022

39

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90240-X

Prostaglandin production by calvariae from sham operated and oophorectomized rats: effect of 17 beta-estradiol in vivo

15 November 2022

43

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90240-X

15 November 2022

Identifiers

1 reference

16 August 2017

1 reference